首页> 美国卫生研究院文献>Journal of Clinical Biochemistry and Nutrition >Gastric peroxisome proliferator activator receptor-γ expression and cytoprotective actions of its ligands against ischemia-reperfusion injury in rats
【2h】

Gastric peroxisome proliferator activator receptor-γ expression and cytoprotective actions of its ligands against ischemia-reperfusion injury in rats

机译:胃过氧化物酶体增殖物激活剂受体γ的表达及其配体对大鼠缺血再灌注损伤的保护作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The beneficial effects by peroxisome proliferator-activated receptor-γ (PPAR-γ) on gastric injury induced by ischemia-reperfusion have been confirmed, however, the precise mechanism of its cytoprotection is not elucidated thoroughly. The aim of the present study was to determine the gastric localization of PPAR-γ expression in the rat gastric mucosa, and to clarify the mechanism of its cytoprotective properties. The gastric expression of PPAR-γ was confirmed by RT-PCR and western blot, and localized on gastric epithelial cells. The protective effect of PPAR-γ ligands, pioglitazone or 15-deoxy-Δ12,14-prostaglandin J2, on gastric ischemia-reperfusion injury was reversed by the co-administration with PPAR-γ antagonist. The gastric expression of tumor necrosis factor-α and cytokine-induced neutrophil chemoattractant-1 increased significantly in rats treated ischemia-reperfusion, and these increases were significantly inhibited by treatment with pioglitazone. Among the 1,032 probes, 18 probes were up-regulated at least 1.5-fold, 17 were down-regulated at least 1.5-fold by pioglitazone. The network including calnexin, endoplasmic reticulum stress protein, heat shock proteins, and proteasome genes was induced by pioglitazone treatment. In conclusion, activation of gastric epithelial PPAR-γ receptor by its ligands may represent a novel therapeutic approach for gastric inflammation via up-regulation of heat shock proteins and endoplasmic reticulum-related proteins.
机译:过氧化物酶体增殖物激活受体-γ(PPAR-γ)对缺血-再灌注引起的胃损伤的有益作用已得到证实,但是其细胞保护的确切机制尚未完全阐明。本研究的目的是确定大鼠胃黏膜中PPAR-γ表达的胃定位,并阐明其细胞保护特性的机制。通过RT-PCR和western blot证实PPAR-γ在胃中的表达,并定位在胃上皮细胞上。与PPAR-γ拮抗剂合用可逆转PPAR-γ配体吡格列酮或15-脱氧-Δ 12,14 -前列腺素J2对胃缺血-再灌注损伤的保护作用。在缺血再灌注大鼠中,肿瘤坏死因子-α和细胞因子诱导的中性粒细胞趋化因子-1的胃表达显着增加,而吡格列酮治疗显着抑制了这些增加。在1,032个探针中,吡格列酮将18个探针上调至少1.5倍,将17个探针下调至少1.5倍。通过吡格列酮处理诱导了包括钙粘蛋白,内质网应激蛋白,热休克蛋白和蛋白酶体基因的网络。总之,通过上调热休克蛋白和内质网相关蛋白,通过其配体激活胃上皮PPAR-γ受体可能代表了一种新型的胃炎治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号